Last update 01 Nov 2024
Benign Pseudohypertrophic Muscular Dystrophy
Last update 01 Nov 2024
Basic Info
Synonyms Benign Pseudohypertrophic Muscular Dystrophy |
Introduction- |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
100 Clinical Results associated with Benign Pseudohypertrophic Muscular Dystrophy
Login to view more data
100 Translational Medicine associated with Benign Pseudohypertrophic Muscular Dystrophy
Login to view more data
Login to view more data
01 Sep 1984Hiroshima journal of medical sciences
One family of benign X-linked pseudohypertrophic muscular dystrophy of early onset.
Article
Author: Kito, S ; Itoga, E
01 Nov 1980Archives of Neurology
Dominantly Inherited Pseudohypertrophic Muscular Dystrophy With Internalized Capillaries
Article
Author: Vick, N. A. ; Groothuis, D. R. ; Hastings, B. A.
01 Jun 1978Pediatriia
[Differential diagnosis of chronic hepatitis and Duchenne's pseudohypertrophic myopathy in children].
Article
Author: Gol'zand, I V ; Savel'eva-Vasil'eva, E A ; Popva, L A
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free